In the human body, moDCs are able to present antigen, which leads to the simulation of CD8+ T-cells, inhibition of tumor growth (Kuhn et al., 2015) and Th17 cell stimulation (Segura et al., 2013). The gene discussed is CD8A; the disease is neoplasm.